Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Director departure Notes underwriting agrmnt
|
Adamis Pharmaceuticals Corp (ADMP)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/01/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
09/20/2022 |
10-K/A
| Annual Report for the period ended December 31, 2021 [amend] |
05/02/2022 |
10-K/A
| Annual Report for the period ended December 31, 2021 [amend] |
04/30/2021 |
10-K/A
| Annual Report for the period ended December 31, 2020 [amend] |
04/29/2020 |
10-K/A
| Annual Report for the period ended December 31, 2019 [amend] |
04/30/2019 |
10-K/A
| Annual Report for the period ended December 31, 2018 [amend] |
04/30/2018 |
10-K/A
| Annual Report for the period ended December 31, 2017 [amend] |
07/26/2013 |
10-K/A
| Annual Report for the period ended March 31, 2013 [amend] |
07/27/2012 |
10-K/A
| Annual Report for the period ended March 31, 2012 [amend] |
07/29/2011 |
10-K/A
| Annual Report for the period ended March 31, 2011 [amend] |
07/29/2010 |
10-K/A
| Annual Report for the period ended March 31, 2010 [amend] |
07/19/2010 |
10-K/A
| Annual Report for the period ended March 31, 2010 [amend] |
04/30/2007 |
10-K/A
| Annual Report for the period ended December 31, 2006 [amend] |
05/01/2006 |
10-K/A
| Annual Report for the period ended December 31, 2005 [amend] |
04/29/2005 |
10-K/A
| Annual Report for the period ended December 31, 2004 [amend] |
03/24/2004 |
10-K/A
| Annual Report for the period ended December 31, 2002 [amend] |
|
|